Trial Profile
Clinical trial of the efficacy of new S-1 schedule (administered 14days followed by 7 days rest) for metastatic or recurrent breast cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms KBCOG13
- 03 Sep 2013 New trial record